Insiders MEI Pharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 26/06/2024 BST			5-day change	1st Jan Change
2.86 ^USD	0.00%		+1.42%	-50.69%

05-09	MEI Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
04-11	MEI Pharma, Inc. Announces Strategic Plan to Leverage Recent Positive Voruciclib and ME-344 Clinical Data	CI

MEI Pharma, Inc. Announces Board Changes	11-01	CI
Anson Funds hires Legion Partners' Gupta to build out activism strategy	03/10/23	RE
MEI Pharma's Finance Chief Brian Drazba to Step Down; Company Names Justin File as Successor	13/06/23	MT
MEI Pharma Names Justin File as Chief Financial Officer	13/06/23	MT
Mei Pharma, Inc. Announces Executive Changes	13/06/23	CI
MEI Pharma Promotes COO David Urso to Chief Executive	02/06/23	MT
MEI Pharma, Inc. Announces Chief Executive Officer Changes	02/06/23	CI
MEI Pharma, Inc. Announces Executive Changes	02/06/23	CI
MEI Pharma, Inc. Announces Management Changes	23/02/23	CI
MEI Pharma, Inc. Announces Management Changes	23/02/23	CI
MEI Pharma, Inc. Announces Chief Executive Officer Changes	23/02/23	CI
MEI Pharma, Inc. Announces Not Stand for Re-Election of Directors	27/10/22	CI
MEI Pharma, Inc. Announces Not Stand for Re-Election of Cheryl L. Cohen as Member of the Board of Directors	07/10/22	CI
Mei Pharma Announces Changes to Board of Directors	22/09/22	CI
MEI Pharma, Inc. Announces Board Changes	15/09/22	CI
Fate Therapeutics Appoints Brian Powl as Chief Commercial Officer	30/06/22	MT
MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer	22/06/22	CI
MEI Pharma, Inc. Announces New Key Executive Appointments	07/02/22	CI
MEI Pharma, Inc. Announces Board Changes	23/11/21	CI
MEI Pharma, Inc. Appoints Tina C. Beamon, J.D., as Chief Compliance Officer	07/07/21	CI

No results for this search